Statistics
Publications
117
Citations
16.5K
H-Index
59
Active since
1995
John C. Byrd is an author at The Ohio State University specializing in medicine, oncology, and chronic lymphocytic leukemia therapy.
Publications per year
1995–2020
117
117
Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
John C. Byrd, Richard R. Furman, Steven Coutré et al. · New England Journal of Medicine · 2013 · 2.2K citations · Full text
Medicine, Hematology, Oncology +12
Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
John C. Byrd, Jennifer R. Brown, Susan O’Brien et al. · New England Journal of Medicine · 2014 · 1.6K citations · Full text
Medicine, Hematology, Oncology +17
1–5 of 117